FDA Drug Application (202801) for LEVOFLOXACIN by HETERO LABS LTD V

Back to FDA Applications sponsored by HETERO LABS LTD V

Application Number202801
Product Number001
FormTABLET;ORAL
Dosage250MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameLEVOFLOXACIN
Active IngredientLEVOFLOXACIN

Active IngredientCount
List of drugs with Active Ingredient LEVOFLOXACIN7
List of drugs with Active Ingredient SODIUM CHLORIDE352


Back to FDA Applications sponsored by HETERO LABS LTD V